InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Elting Kimberley A., Directrice Juridique et Développement. Insider active across 1 companies, notably Orthofix Medical Inc.. In total, 10 filings have been published. Total volume traded: €54k. The latest transaction was disclosed on 11 April 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations10 total
029,874 shares0
Common Stock
SEC:0001209191-22-024288:0·
€10,563354 shares@ €29.84010.0017% mcap9.3% of flow
Common Stock
SEC:0001209191-22-023337:0·
020,492 shares0
Common Stock
SEC:0001209191-22-006837·
020,492 shares0
Common Stock
SEC:0001209191-22-006837:0·
€26,7991,000 shares@ €26.79930.0044% mcap51.8% of flow
Common Stock
SEC:0001209191-21-065545·
Ideal exit: 15 Aug 2022 (T+270)
€26,7991,000 shares@ €26.79930.0044% mcap23.5% of flow
Common Stock
SEC:0001209191-21-065545:0·
Ideal exit: 15 Aug 2022 (T+270)
€13,109365 shares@ €35.91640.0022% mcap25.3% of flow
Common Stock
SEC:0001209191-21-055054·
€13,109365 shares@ €35.91640.0022% mcap11.5% of flow
Common Stock
SEC:0001209191-21-055054:0·
€11,823346 shares@ €34.17120.0020% mcap22.9% of flow
Common Stock
SEC:0001209191-21-045860·
€11,823346 shares@ €34.17120.0020% mcap10.4% of flow
Common Stock
SEC:0001209191-21-045860:0·
10 of 10 declarations
About Elting Kimberley A.
Kimberley A. Elting is the Chief Legal & Development Officer and President of Global Orthopedics at Orthofix Medical Inc. She is responsible for managing legal affairs and the strategic development of the company. Her role involves ensuring regulatory compliance and aligning development objectives. With her expertise, she contributes to the overall performance of the company.
